Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi Study.
Cerebral revascularization
Children
Delphi technique
Ischemic stroke
Moyamoya disease
Pediatric stroke
Perioperative care
Journal
Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086
Informations de publication
Date de publication:
20 Jul 2023
20 Jul 2023
Historique:
received:
13
05
2023
accepted:
20
06
2023
medline:
20
7
2023
pubmed:
20
7
2023
entrez:
20
7
2023
Statut:
aheadofprint
Résumé
Surgical revascularization decreases the long-term risk of stroke in children with moyamoya arteriopathy but can be associated with an increased risk of stroke during the perioperative period. Evidence-based approaches to optimize perioperative management are limited and practice varies widely. Using a modified Delphi process, we sought to establish expert consensus on key components of the perioperative care of children with moyamoya undergoing indirect revascularization surgery and identify areas of equipoise to define future research priorities. Thirty neurologists, neurosurgeons, and intensivists practicing in North America with expertise in the management of pediatric moyamoya were invited to participate in a three-round, modified Delphi process consisting of a 138-item practice patterns survey, anonymous electronic evaluation of 88 consensus statements on a 5-point Likert scale, and a virtual group meeting during which statements were discussed, revised, and reassessed. Consensus was defined as ≥ 80% agreement or disagreement. Thirty-nine statements regarding perioperative pediatric moyamoya care for indirect revascularization surgery reached consensus. Salient areas of consensus included the following: (1) children at a high risk for stroke and those with sickle cell disease should be preadmitted prior to indirect revascularization; (2) intravenous isotonic fluids should be administered in all patients for at least 4 h before and 24 h after surgery; (3) aspirin should not be discontinued in the immediate preoperative and postoperative periods; (4) arterial lines for blood pressure monitoring should be continued for at least 24 h after surgery and until active interventions to achieve blood pressure goals are not needed; (5) postoperative care should include hourly vital signs for at least 24 h, hourly neurologic assessments for at least 12 h, adequate pain control, maintaining normoxia and normothermia, and avoiding hypotension; and (6) intravenous fluid bolus administration should be considered the first-line intervention for new focal neurologic deficits following indirect revascularization surgery. In the absence of data supporting specific care practices before and after indirect revascularization surgery in children with moyamoya, this Delphi process defined areas of consensus among neurosurgeons, neurologists, and intensivists with moyamoya expertise. Research priorities identified include determining the role of continuous electroencephalography in postoperative moyamoya care, optimal perioperative blood pressure and hemoglobin targets, and the role of supplemental oxygen for treatment of suspected postoperative ischemia.
Sections du résumé
BACKGROUND
BACKGROUND
Surgical revascularization decreases the long-term risk of stroke in children with moyamoya arteriopathy but can be associated with an increased risk of stroke during the perioperative period. Evidence-based approaches to optimize perioperative management are limited and practice varies widely. Using a modified Delphi process, we sought to establish expert consensus on key components of the perioperative care of children with moyamoya undergoing indirect revascularization surgery and identify areas of equipoise to define future research priorities.
METHODS
METHODS
Thirty neurologists, neurosurgeons, and intensivists practicing in North America with expertise in the management of pediatric moyamoya were invited to participate in a three-round, modified Delphi process consisting of a 138-item practice patterns survey, anonymous electronic evaluation of 88 consensus statements on a 5-point Likert scale, and a virtual group meeting during which statements were discussed, revised, and reassessed. Consensus was defined as ≥ 80% agreement or disagreement.
RESULTS
RESULTS
Thirty-nine statements regarding perioperative pediatric moyamoya care for indirect revascularization surgery reached consensus. Salient areas of consensus included the following: (1) children at a high risk for stroke and those with sickle cell disease should be preadmitted prior to indirect revascularization; (2) intravenous isotonic fluids should be administered in all patients for at least 4 h before and 24 h after surgery; (3) aspirin should not be discontinued in the immediate preoperative and postoperative periods; (4) arterial lines for blood pressure monitoring should be continued for at least 24 h after surgery and until active interventions to achieve blood pressure goals are not needed; (5) postoperative care should include hourly vital signs for at least 24 h, hourly neurologic assessments for at least 12 h, adequate pain control, maintaining normoxia and normothermia, and avoiding hypotension; and (6) intravenous fluid bolus administration should be considered the first-line intervention for new focal neurologic deficits following indirect revascularization surgery.
CONCLUSIONS
CONCLUSIONS
In the absence of data supporting specific care practices before and after indirect revascularization surgery in children with moyamoya, this Delphi process defined areas of consensus among neurosurgeons, neurologists, and intensivists with moyamoya expertise. Research priorities identified include determining the role of continuous electroencephalography in postoperative moyamoya care, optimal perioperative blood pressure and hemoglobin targets, and the role of supplemental oxygen for treatment of suspected postoperative ischemia.
Identifiants
pubmed: 37470933
doi: 10.1007/s12028-023-01788-0
pii: 10.1007/s12028-023-01788-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society.
Références
Ferriero D, Fullerton H, Bernard T, et al. Management of stroke in neonates and children: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2019;50:e51-96.
doi: 10.1161/STR.0000000000000183
pubmed: 30686119
Lee S, Rivkin MJ, Kirton A, deVeber G, Elbers J. Moyamoya disease in children: results from the international pediatric stroke study. J Child Neurol. 2017;32:924–9.
doi: 10.1177/0883073817718730
pubmed: 28715924
Ganesan V, Prengler M, Wade A, Kirkham FJ. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation. 2006;114:2170–7.
doi: 10.1161/CIRCULATIONAHA.105.583690
pubmed: 17075014
Fullerton H, Wintermark M, Hills N, et al. Risk of recurrent arterial ischemic stroke in childhood: a prospective international study. Stroke. 2016;47:53–9.
doi: 10.1161/STROKEAHA.115.011173
pubmed: 26556824
Gatti JR, Torriente AG, Sun LR. Clinical presentation and stroke incidence differ by moyamoya etiology. J Child Neurol. 2021;36:272–80.
doi: 10.1177/0883073820967160
pubmed: 33155871
Kaseka ML, Slim M, Muthusami P, et al. Distinct clinical and radiographic phenotypes in pediatric patients with moyamoya. Pediatr Neurol. 2021;120:18–26.
doi: 10.1016/j.pediatrneurol.2021.03.002
pubmed: 33962345
Hall EM, Leonard J, Smith JL, et al. Reduction in overt and silent stroke recurrence rate following cerebral revascularization surgery in children with sickle cell disease and severe cerebral vasculopathy. Pediatr Blood Cancer. 2016;63:1431–7.
doi: 10.1002/pbc.26022
pubmed: 27106860
pmcid: 5443666
Fung LE, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005;21:358–64.
doi: 10.1007/s00381-004-1118-9
pubmed: 15696334
Ng J, Thompson D, Lumley JPS, Saunders DE, Ganesan V. Surgical revascularisation for childhood moyamoya. Childs Nerv Syst. 2012;28:1041–8.
doi: 10.1007/s00381-012-1743-7
pubmed: 22570164
Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. J Neurosurg. 2004;100:142–9.
pubmed: 14758941
Araki Y, Yokoyama K, Uda K, et al. Postoperative stroke and neurological outcomes in the early phase after revascularization surgeries for moyamoya disease: an age-stratified comparative analysis. Neurosurg Rev. 2021;44:2785–95.
doi: 10.1007/s10143-020-01459-0
pubmed: 33415521
Lu J, Zhao Y, Ma L, et al. Predictors and clinical features of transient neurological events after combined bypass revascularization for moyamoya disease. Clin Neurol Neurosurg. 2019;186:105505.
doi: 10.1016/j.clineuro.2019.105505
pubmed: 31622898
Iwama T, Hashimoto N, Yonekawa Y. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery. 1996;38:1120–6.
pubmed: 8727141
Gardner Yelton SE, Gatti J, Adil M, Guryildirim M, Tekes A, Sun LR. Risk factors and imaging biomarkers associated with perioperative stroke in pediatric moyamoya arteriopathy. J Child Neurol. 2022;37:963–9.
doi: 10.1177/08830738221125554
pubmed: 36128779
Gardner Yelton SE, Williams MA, Young M, et al. Perioperative management of pediatric patients with moyamoya arteriopathy. J Pediatr Intensive Care. 2021.
Fujimura M, Tominaga T, Kuroda S, et al. 2021 Japanese guidelines for the management of moyamoya disease: guidelines from the research committee on moyamoya disease and Japan Stroke Society. Neurol Med Chir. 2022;62:165–70.
doi: 10.2176/jns-nmc.2021-0382
Smith ER, Scott MR. Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines: a review. J Neurosurg Pediatr. 2012;9:353–60.
doi: 10.3171/2011.12.PEDS1172
pubmed: 22462697
Sun LR, Hersh DS, Smith ER, Aldana PR, Jordan LC. Practice variability in the perioperative management of pediatric moyamoya disease in North America. J Stroke Cerebrovasc Dis. 2023;32:107029.
doi: 10.1016/j.jstrokecerebrovasdis.2023.107029
pubmed: 36706654
Amin-Hanjani S, Riina HA, Barker FG. Editorial. Delphi studies in neurosurgery. J Neurosurg. 2022;136:1217–8.
doi: 10.3171/2021.4.JNS21622
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
doi: 10.1016/j.jbi.2019.103208
pubmed: 31078660
pmcid: 7254481
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.
doi: 10.1016/j.jbi.2008.08.010
pubmed: 18929686
Kim S, Choi J, Yang K, Kim T, Kim D. Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg. 2005;103:433–8.
pubmed: 16302615
Muraoka S, Araki Y, Kondo G, et al. Postoperative cerebral infarction risk factors and postoperative management of pediatric patients with moyamoya disease. World Neurosurg. 2018;113:e190–9.
doi: 10.1016/j.wneu.2018.01.212
pubmed: 29432946
Funaki T, Takahashi JC, Takagi Y, et al. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications. J Neurosurg. 2015;122:400–7.
doi: 10.3171/2014.10.JNS14231
pubmed: 25423271
Sakamoto T, Kawaguchi M, Kurehara K, Kitaguchi K, Furuya H, Karasawa J. Postoperative neurological deterioration following the revascularization surgery in children with moyamoya disease. J Neurosurg Anesthesiol. 1998;10:37–41.
doi: 10.1097/00008506-199801000-00009
pubmed: 9438618
Hara S, Nariai T, Inaji M, Tanaka Y, Maehara T. Imaging Pattern and the mechanisms of postoperative infarction after indirect revascularization in patients with moyamoya disease. World Neurosurg. 2021;155:e510–21.
doi: 10.1016/j.wneu.2021.08.098
pubmed: 34464770
Pettersson SD, Olofsson HKL, Ali S, Szarek D, Miękisiak G, Ogilvy CS. Risk Factors for ischemic stroke after revascularization surgery in patients with moyamoya disease: an age-stratified comparative meta-analysis. World Neurosurg. 2023.
Kanamori F, Araki Y, Yokoyama K, et al. Effects of aspirin and heparin treatment on perioperative outcomes in patients with Moyamoya disease. Acta Neurochir. 2021;163:1485–91.
doi: 10.1007/s00701-020-04668-0
pubmed: 33404873
Kim JS. Moyamoya disease: epidemiology, clinical features, and diagnosis. J Stroke. 2016;18:2–11.
doi: 10.5853/jos.2015.01627
pubmed: 26846755
pmcid: 4747069
Baang HY, Chen HY, Herman AL, et al. The utility of quantitative EEG in detecting delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Clin Neurophysiol. 2022;39:207–15.
doi: 10.1097/WNP.0000000000000754
pubmed: 34510093
pmcid: 8901442
Huguenard AL, Guerriero RM, Tomko SR, et al. Immediate postoperative electroencephalography monitoring in pediatric moyamoya disease and syndrome. Pediatr Neurol. 2021;118:40–5.
doi: 10.1016/j.pediatrneurol.2021.02.004
pubmed: 33773289
Howard J. Sickle cell disease: when and how to transfuse. Hematology. 2016;2016:625–31.
doi: 10.1182/asheducation-2016.1.625
pubmed: 27913538
pmcid: 6142434
Howard J, Malfroy M, Llewelyn C, et al. The transfusion alternatives preoperatively in sickle cell disease (TAPS) study: a randomised, controlled, multicentre clinical trial. The Lancet (Bri Edit). 2013;381:930–8.
doi: 10.1016/S0140-6736(12)61726-7
Chou ST, Alsawas M, Fasano RM, et al. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv. 2020;4:327–55.
doi: 10.1182/bloodadvances.2019001143
pubmed: 31985807
pmcid: 6988392
Valentine SL, Bembea MM, Muszynski JA, et al. Consensus recommendations for RBC transfusion practice in critically Ill children from the pediatric critical care transfusion and anemia expertise initiative. Pediatr Crit Care Med. 2018;19:884–98.
doi: 10.1097/PCC.0000000000001613
pubmed: 30180125
pmcid: 6126913
Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356:1609–19.
doi: 10.1056/NEJMoa066240
pubmed: 17442904
Choi JW, Chong S, Phi JH, et al. Postoperative symptomatic cerebral infarction in pediatric moyamoya disease: risk factors and clinical outcome. World Neurosurg. 2019;136:e158–64.
doi: 10.1016/j.wneu.2019.12.072
pubmed: 31870818
Mendez NV, Chen C, Richardson AM, Morcos JJ, Deepika K. Hemoglobin Concentration may influence the incidence of postoperative transient neurological events in patients with moyamoya after extracranial-intracranial arterial bypass: a retrospective single center experience. J Neurosurg Anesthesiol. 2022;34:238–42.
doi: 10.1097/ANA.0000000000000742
pubmed: 33165164
Rumalla K, Srinivasan VM, Catapano JS, Lawton MT. Response To "Hemoglobin concentration may influence the incidence of postoperative transient neurological events in patients with moyamoya after extracranial-intracranial arterial bypass: a retrospective single center experience." J Neurosurg Anesthesiol. 2021; Publish Ahead of Print.
Penn R, Harrar D, Sun LR. Seizures, epilepsy, and electroencephalography findings in pediatric moyamoya arteriopathy: a scoping review. Pediatr Neurol. 2022.
Wieczorek B, Ascenzi J, Kim Y, et al. PICU Up!: impact of a quality improvement intervention to promote early mobilization in critically ill children. Pediatr Crit Care Med. 2016;17:e559–66.
doi: 10.1097/PCC.0000000000000983
pubmed: 27759596
pmcid: 5138131
Kirschen MP, LaRovere K, Balakrishnan B, et al. A survey of neuromonitoring practices in North American pediatric intensive care units. Pediatr Neurol. 2022;126:125–30.
doi: 10.1016/j.pediatrneurol.2021.11.002
pubmed: 34864306
Harrar DB, Sun LR, Segal JB, Lee S, Sansevere AJ. Neuromonitoring in children with cerebrovascular disorders. Neurocrit Care 2023.
Gatti JR, Sun LR. Nonischemic presentations of pediatric moyamoya arteriopathy: a natural history study. Stroke. 1970;2022(53):e219–20.